US28623U1016 - ELEV (XNAS)
Elevation Oncology, Inc. - Common stock Acción
0,58 USD
Cotizaciones actuales de Elevation Oncology, Inc. - Common stock
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria | Variación diaria % |
---|---|---|---|---|---|---|
NASDAQ |
ELEV
|
USD
|
24.12.2024 22:45
|
0,58 USD
| 0,57 USD | 2,28 % |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
0,00 % | -15,08 % | -3,94 % | -2,47 % | -76,34 % | 23,32 % | -94,93 % |
Company Profile for Elevation Oncology, Inc. - Common stock Share
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.
Company Data for Elevation Oncology, Inc. - Common stock Share
Name Elevation Oncology, Inc. - Common stock
Company Elevation Oncology, Inc.
Symbol ELEV
Website https://elevationoncology.com
Primary Exchange
NASDAQ
ISIN US28623U1016
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Joseph J. Ferra Jr.
Market Capitalization 34 Mio
Country United States of America
Currency USD
Employees 0,0 T
Address 888 Seventh Avenue, 10106 New York
IPO Date 2021-06-25
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | ELEV |
More Shares
Investors who Elevation Oncology, Inc. - Common stock hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.